NCT07204028

Brief Summary

The synthesis of progesterone by corpus luteum is extremely important for the maintenance of normal pregnancy in the first seven weeks. Similarly, the production of progesterone by the placental syncytiotrophoblast increases progressively during the first weeks of gestation, so that in eight and a half weeks the placenta and corpus luteum contribute in equal amounts of progesterone. However, from the eighth week, the placental contribution is sufficient to maintain gestation. Angiogenesis in the corpus luteum occurs under physiologic circumstances in each menstrual cycle and functionally is very important for maintenance of early pregnancy. This role implies a potential correlation between abnormal function of corpus luteum and possible abnormal pregnancy including abortion. Using color Doppler sonography, it was feasible to distinguish the ovary containing an active corpus luteum from the inactive ovary. The technique is simple to use, and the results are displayed obviously.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 24, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 2, 2025

Completed
Last Updated

March 2, 2026

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

September 24, 2025

Last Update Submit

February 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • New predictors of first trimester pregnancy outcome

    Evaluation of corpus luteum Doppler as predictor of first trimester outcome.

    6 months

Eligibility Criteria

AgeUp to 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant female aged less than 40 years at 6-12 weeks.

You may qualify if:

  • The age of women in the studied population was up to 40 years.
  • Live singleton pregnancy with gestational age 6-9 gestational weeks.
  • Patients with threatened miscarriage were included.

You may not qualify if:

  • Ectopic pregnancy.
  • Multiple pregnancies.
  • Vesicular mole.
  • Miscarriage in first visit.
  • Fetal anomaly.
  • Known uterine anomalies.
  • Significant pre-pregnancy maternal diseases (e.g., hypertension - diabetes mellitus-systemic lupus) or known thrombophilia (e.g., antiphospholipid syndrome).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Cairo University

Giza, Cairo Governorate, 4240310, Egypt

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor at obstetrics and gynecology department

Study Record Dates

First Submitted

September 24, 2025

First Posted

October 2, 2025

Study Start

January 1, 2025

Primary Completion

July 1, 2025

Study Completion

July 21, 2025

Last Updated

March 2, 2026

Record last verified: 2025-09

Locations